Asada Kayo 浅田佳代

Researcher Number	50805843
Affiliation (Current)	2026: 東京大学, 医学部附属病院, 助教
Affiliation (based on the past Project Information) *help	2019 – 2021: 東京大学, 医学部附属病院, 届出研究員 2018: 東京大学, 医学部附属病院, 登録研究員
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 免疫チェックポイント阻害剤 / PARP阻害剤 / 相同組換修復関連遺伝子変異 / 卵巣高異型度漿液性癌 / 統合的ゲノム解析

Exploration of Therapeutic Target Pathways Involving DNA Repair Genes in High Grade Serous Ovarian CarcinomaPrincipal Investigator
- Principal Investigator
  
  Asada Kayo
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  The University of Tokyo

All 2020 2019 2018

All Journal Article Presentation

[Journal Article] Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma2020
- Author(s)
  Matsushita Hirokazu、Hasegawa Kosei、Oda Katsutoshi、Yamamoto Shogo、Asada Kayo、Karasaki Takahiro、Yabuno Akira、Nishijima Akira、Nejo Takahide、Kobayashi Yukari、Sato Sho、Ikeda Yuji、Miyai Manami、Takahashi Yusuke、Yamaguchi Rui、Fujiwara Keiichi、Aburatani Hiroyuki、Kakimi Kazuhiro
- Journal Title
  
  Journal for ImmunoTherapy of Cancer
  
  Volume: 8 Issue: 1 Pages: e000375-e000375
- DOI
  10.1136/jitc-2019-000375
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15304, KAKENHI-PROJECT-18K09249
[Journal Article] Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report2020
- Author(s)
  Sone Kenbun、Eguchi Satoko、Asada Kayo、Inoue Futaba、Miyamoto Yuichiro、Tanikawa Michihiro、Tsuruga Tetsushi、Mori?Uchino Mayuyo、Matsumoto Yoko、Hiraike?Wada Osamu、Oda Katsutoshi、Osuga Yutaka、Fujii Tomoyuki
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 13 Issue: 2 Pages: 141-145
- DOI
  10.3892/mco.2020.2053
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15304, KAKENHI-PROJECT-20H03820, KAKENHI-PROJECT-18K09249
[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.2019
- Author(s)
  Kukita A, Sone K, Oda K, Hamamoto R, Kaneko S, Komatsu M, Wada M, Honjoh H, Kawata Y, Kojima M, Oki S, Sato M, Asada K, Taguchi A, Miyasaka A, Tanikawa M, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Osuga Y, Fujii T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: in press Issue: 2 Pages: 30555-8
- DOI
  10.1016/j.bbrc.2019.03.155
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K09249, KAKENHI-PROJECT-16K21330, KAKENHI-PROJECT-18K09248, KAKENHI-PROJECT-18K11542, KAKENHI-PROJECT-18K15304, KAKENHI-PUBLICLY-18H04908, KAKENHI-PROJECT-19H03429, KAKENHI-PROJECT-17K11268, KAKENHI-PROJECT-18K16757, KAKENHI-PROJECT-18K16759
[Journal Article] The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation2019
- Author(s)
  Kojima Machiko、Sone Kenbun、Wada-Hiraike Osamu、Osuga Yutaka、Fujii Tomoyuki
- Journal Title
  
  BMC Cancer
  
  Volume: 19 Issue: 1 Pages: 455-455
- DOI
  10.1186/s12885-019-5638-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09248, KAKENHI-PROJECT-18K11542, KAKENHI-PROJECT-19K09775, KAKENHI-PROJECT-18K15304, KAKENHI-PUBLICLY-18H04908, KAKENHI-PROJECT-19H03429, KAKENHI-PROJECT-17K11268, KAKENHI-PROJECT-18K16759
[Presentation] Genomic characterization of high grade serous ovarian carcinoma2018
- Author(s)
  Kayo Asada
- Organizer
  International Gynecologic Cancer Society
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15304

1. ODA Katsutoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. HIRAIKE Osamu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Asada Kayo 浅田佳代

Research Projects

Research Products

Co-Researchers

Exploration of Therapeutic Target Pathways Involving DNA Repair Genes in High Grade Serous Ovarian CarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Genomic characterization of high grade serous ovarian carcinoma2018

Author(s)

Organizer

Data Source

Asada Kayo 浅田 佳代

Research Projects

Research Products

Co-Researchers

Exploration of Therapeutic Target Pathways Involving DNA Repair Genes in High Grade Serous Ovarian CarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] Genomic characterization of high grade serous ovarian carcinoma2018

Author(s)

Organizer

Data Source

Asada Kayo 浅田佳代